StocktradeC

First FDA clearance for AI X-ray system

NYSE:GE   GE Aerospace
GE's (GE +1%) health unit has won FDA approval for a new artificial intelligence-powered X-ray device that reduces the time to diagnose and treat a collapsed lung from eight hours to as little as 15 minutes.

The device, called the Critical Care Suite, uses AI algorithms to scan X-ray images and detect pneumothorax, which affects approximately 74K Americans each year.

GE is also working to enhance the technology to detect other health conditions.

source

For more analysis and articles visit our website.
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.